Standout Papers
Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
2003 StandoutScienceNobel
Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer
2006
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
2014
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
2011
Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status
2004
Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen
2003
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
2005
The development and clinical use of trastuzumab (Herceptin).
2002
HER-2/neu Overexpression and Response to Oophorectomy Plus Tamoxifen Adjuvant Therapy in Estrogen Receptor-Positive Premenopausal Women With Operable Breast Cancer
2003
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Overcoming Endocrine Therapy Resistance by Signal Transduction Inhibition
2004
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003
HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer
2004
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study
2006
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin
2004 StandoutNobel
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
2006
Caught up in a Wnt storm: Wnt signaling in cancer
2003
Dependence of intestinal granuloma formation on unique myeloid DC-like cells
2007
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Breast cancer
2016 Standout
Improved methods for the generation of human gene knockout and knockin cell lines
2005
Mitochondrial DNA mutations in human cancer
2006
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
Aromatase Inhibitors in Breast Cancer
2003
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Reduced Expression of PTEN Protein and Its Prognostic Implications in Invasive Ductal Carcinoma of the Breast
2005
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
2007 StandoutNatureNobel
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer
2003
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
2012 StandoutNatureNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
2011
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Inflammatory bowel disease: cause and immunobiology
2007 Standout
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
1998 StandoutNobel
Intestinal Dendritic Cells
2010
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
PTEN: One Gene, Many Syndromes
2003
The Intestinal Wnt/TCF Signature
2006
Mapping and analysis of chromatin state dynamics in nine human cell types
2011 StandoutNature
Significance, detection and markers of disseminated breast cancer cells
2006
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
2006
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated Colitis
2010
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer
2004
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
2012
Cancer immunotherapy comes of age
2011 StandoutNature
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Regulatory T cells in the control of immune pathology
2001
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Wnt signalling in stem cells and cancer
2005 StandoutNature
The acute respiratory distress syndrome
2012 Standout
Identification of stem cells in small intestine and colon by marker gene Lgr5
2007 StandoutNature
The HER2 Extracellular Domain as a Prognostic and Predictive Factor in Breast Cancer
2002
Interactions between dendritic cells and bacteria in the regulation of intestinal immunity
2004
Plasma angiopoietin-2 in clinical acute lung injury
2012
The cancer genome
2009 StandoutNature
Future Research Directions in Acute Lung Injury
2003
Acute Lung Injury and the Acute Respiratory Distress Syndrome
2005
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.
2002
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006
Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists
2005
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance
2004
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer
2008
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation
2006
Wastewater Treatment Works (WwTW) as a Source of Microplastics in the Aquatic Environment
2016 Standout
Circulating tumor cells: approaches to isolation and characterization
2011
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
2001
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease
2006
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer
2005
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
2005
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer
2005
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Global cancer statistics, 2012
2015 Standout
Tolerogenic Dendritic Cells
2003 StandoutNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
The Phosphoinositide 3-Kinase Pathway
2002 StandoutScience
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer
2006
Works of Baljit Singh being referenced
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
2015
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer
2002
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
2001
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
2009
Pressure is proinflammatory in lung venular capillaries
1999
Breast Cancer in Young Women
2008
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?
2011
Detection of LOH and Mitochondrial DNA Alterations in Ductal Lavage and Nipple Aspirate Fluids from High-risk Patients
2004
Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus
1998
Mechanistic implications of plastic degradation
2007 Standout
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
2003
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
2002
CD134L Expression on Dendritic Cells in the Mesenteric Lymph Nodes Drives Colitis in T Cell-Restored SCID Mice
2001
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.
2002
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
2003